Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1 Clinical Trial Using Autologous, MUC1-Activated T Cells Expanded From Peripheral Blood in Patients With Relapsed and Resistant Ovarian Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06483048
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:12.799038+00:00
Published At
2026-03-16T00:00:00+00:00
Record Updated At
2026-03-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Platinum-Resistant Fallopian Tube Carcinoma", "Platinum-Resistant Ovarian Carcinoma", "Platinum-Resistant Primary Peritoneal Carcinoma", "Recurrent Fallopian Tube Carcinoma", "Recurrent Fallopian Tube Carcinosarcoma", "Recurrent Female Reproductive System Carcinoma", "Recurrent Ovarian Carcinoma", "Recurrent Ovarian Carcinosarcoma", "Recurrent Platinum-Resistant Fallopian Tube Carcinoma", "Recurrent Platinum-Resistant Ovarian Carcinoma", "Recurrent Primary Peritoneal Carcinoma", "Recurrent Primary Peritoneal Carcinosarcoma", "Refractory Fallopian Tube Carcinoma", "Refractory Female Reproductive System Carcinoma", "Refractory Ovarian Carcinoma", "Refractory Primary Peritoneal Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-16"
protocolSection.identificationModule.nctId
"NCT06483048"
protocolSection.identificationModule.officialTitle
"Phase 1 Clinical Trial Using Autologous, MUC1-Activated T Cells Expanded From Peripheral Blood in Patients With Relapsed and Resistant Ovarian Cancer"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Platinum-Resistant Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Platinum-Resistant Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Platinum-Resistant Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Fallopian Tube Carcinosarcoma (protocolSection.conditionsModule.conditions)
  • Recurrent Female Reproductive System Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Ovarian Carcinosarcoma (protocolSection.conditionsModule.conditions)
  • Recurrent Platinum-Resistant Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Platinum-Resistant Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Primary Peritoneal Carcinosarcoma (protocolSection.conditionsModule.conditions)
  • Refractory Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Female Reproductive System Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.